|Articles|July 25, 2022
Osmolality monitoring for UF/DF and CEX capture of mAbs from mammalian cell cultures
Author(s)Advanced Instruments
The goal of this paper is to introduce and support the use of osmolality in the Downstream Ultrafiltration/Diafiltration (UF/DF) process steps in the mAb workflow.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Why Biopharma Developers Should Care About FDA’s New Personalized Therapy Approval Process
2
Chiesi–Aliada Partnership Advances BBB-Crossing Technology for Lysosomal Storage Disorders
3
How Advanced PK/TK Protocols Strengthen Data Integrity
4
